CardioInsight Technologies
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Spinout | |
$300k | Series A | ||
$6.0m | Series B | ||
N/A | $4.0m | Early VC | |
$50.0k | Series B | ||
N/A | $1.7m | Debt | |
N/A | $7.5m | Early VC | |
$7.5m | Series C | ||
$15.0m | Series C | ||
$93.0m | Acquisition | ||
Total Funding | AUD62.4m |
Related Content
Recent News about CardioInsight Technologies
EditCardioInsight operates in the medical technology sector, specializing in advanced cardiac mapping solutions. The company serves healthcare providers, including hospitals and cardiology clinics, by offering non-invasive, real-time 3D mapping technology to diagnose and treat arrhythmias. This technology allows for precise localization of cardiac electrical activity, improving the accuracy of diagnoses and the effectiveness of treatments. CardioInsight's business model revolves around the sale and leasing of its proprietary mapping systems, as well as providing ongoing support and maintenance services. Revenue is generated through the initial sale or lease agreements, as well as recurring income from service contracts and consumables. The market for CardioInsight's products includes both domestic and international healthcare institutions, with a focus on regions with advanced healthcare infrastructure. The company aims to enhance patient outcomes and streamline clinical workflows, thereby reducing overall healthcare costs.
Keywords: cardiac mapping, arrhythmia diagnosis, non-invasive, real-time 3D mapping, healthcare providers, cardiology clinics, medical technology, patient outcomes, clinical workflows, healthcare costs.